Shandong Lukang Pharmaceutical Co (SHSE:600789) 3-Year EBITDA Growth Rate : 23.00% (As of Dec. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co 3-Year EBITDA Growth Rate?

Shandong Lukang Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2024 was ¥0.09.

During the past 12 months, Shandong Lukang Pharmaceutical Co's average EBITDA Per Share Growth Rate was 21.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 23.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shandong Lukang Pharmaceutical Co was 58.70% per year. The lowest was -30.20% per year. And the median was 13.60% per year.

Competitive Comparison of Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Shandong Lukang Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shandong Lukang Pharmaceutical Co (SHSE:600789) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shandong Lukang Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Lukang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 152 Taibai West Road, Jining, Shandong, CHN, 272021

Website

http://www.lkpc.com

Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.

Executives

Zhao Wei	Director
Peng Xin	Director
Dong Kun	Director
He De Feng	senior management
Gao Xiang You	Director
Cheng Jun	Director

Shandong Lukang Pharmaceutical Co Headlines

No Headlines